0
0.5
1
1.5
2+
Viral clearance time
-3%
Improvement
Relative Risk
Viral clearance time (b)
59%
Favipiravir for COVID-19 Hafez et al. LATE TREATMENT
Is late treatment with favipiravir + HCQ beneficial for COVID-19?
Retrospective 1,505 patients in United Arab Emirates
No significant difference in viral clearance
c19early.org
Hafez et al., Antibiotics, April 2022
Favors favipiravir
Favors control